We have been able to amplify the lysine binding pocket region of human
apo(a) kringle type 5 starting from the DNA isolated from peripheral
blood lymphocytes. This development now permits the identification of
Lp(a) mutants that by lacking their ability to bind to lysine/fibrin w
ould have a lesser thrombogenic potential.